Published in J Hepatol on October 01, 2001
Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine. Wien Klin Wochenschr (2004) 1.42
Combination therapy with interferon-alpha(2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin. Dig Dis Sci (2003) 0.81
Amantadine: a different approach. J Hepatol (2002) 0.77
Amantadine for chronic hepatitis c: a magic bullet or yet another dead duck? J Hepatol (2001) 0.76
Rapid responses of British butterflies to opposing forces of climate and habitat change. Nature (2001) 8.75
Comparative losses of British butterflies, birds, and plants and the global extinction crisis. Science (2004) 6.18
Increase in primary liver cancer in the UK, 1979-94. Lancet (1997) 6.15
The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care (2008) 4.59
Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med (2001) 4.10
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
The teacher as observer and experimenter in the modification of disputing and talking-out behaviors. J Appl Behav Anal (1971) 3.36
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology (1998) 3.31
Natural history of early primary biliary cirrhosis. Lancet (1996) 3.24
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10
Fluconazole resistant candida in AIDS. J Infect (1991) 2.97
Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet (1981) 2.95
Mother Theresa's care for the dying. Lancet (1994) 2.72
Selective vagotomy without drainage. An interim report. Br Med J (1969) 2.58
Misuse of temazepam. BMJ (1992) 2.49
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Hospitalised adult patients with Suspected 2009 H1N1 Infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses. J Infect (2009) 2.24
Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry (1999) 2.09
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood (1996) 2.06
Information Technology for postgraduate education: survey of facilities and skills in the South West Deanery. Br J Obstet Gynaecol (1999) 2.04
Prefer diazepam for initial control of pre-eclamptic fits. BMJ (1995) 2.04
Upper abdominal pain in pregnancy may indicate pre-eclampsia. BMJ (1994) 2.04
Hepatitis C virus infection and liver disease in blood donors. Br J Hosp Med (1994) 2.04
Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol (1999) 2.02
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet (1996) 2.01
Responses of butterflies to twentieth century climate warming: implications for future ranges. Proc Biol Sci (2002) 2.00
Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab (1990) 1.99
Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut (2005) 1.99
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect (2000) 1.94
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology (1997) 1.94
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut (2004) 1.93
Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology (2000) 1.92
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem (1996) 1.92
Evidence for a cerebral effect of the hepatitis C virus. Lancet (2001) 1.90
Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet (1988) 1.90
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology (1999) 1.86
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology (1998) 1.84
Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol (1993) 1.83
Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer (1998) 1.81
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis (1993) 1.80
Quality improvement demands quality measurement. BJOG (2010) 1.78
Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet (1983) 1.78
Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis (1998) 1.77
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom. J Clin Microbiol (2001) 1.75
Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat (2005) 1.74
Birthing pools and the fetus. Lancet (1993) 1.73
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. J Thromb Haemost (2008) 1.72
Improving diabetes care in the primary healthcare setting: a randomised cluster trial in remote Indigenous communities. Med J Aust (2001) 1.71
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum (2001) 1.68
Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut (2000) 1.68
Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res (1991) 1.66
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology (1996) 1.65
Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci U S A (1991) 1.64
Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat (2009) 1.63
Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest (1997) 1.62
Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A (1988) 1.62
Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. Psychol Med (1997) 1.61
Scar formation after stereotactic vacuum-assisted core biopsy of benign breast lesions. Clin Radiol (2006) 1.60
Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun (2000) 1.59
Assignment of segments of the bacteriorhodopsin sequence to positions in the structural map. Biophys J (1983) 1.58
LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet (1998) 1.57
Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM (2009) 1.57
Midazolam co-induction and laryngeal mask insertion. Anaesthesia (1996) 1.55
The perception of biological motion by human infants. Science (1982) 1.54
Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet (1994) 1.53
Effect of HIV posttest counseling on STD incidence. JAMA (1992) 1.53
The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med (1979) 1.53
Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study. Thorax (2004) 1.52
Co-induction and laryngeal mask insertion. A comparison of thiopentone versus propofol. Anaesthesia (1997) 1.52
Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology (1992) 1.52
Oral health of patients with hepatitis C virus infection: a pilot study. Oral Dis (2001) 1.52
Should coronary angiography be performed in district hospitals? Br Heart J (1990) 1.52
Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Am J Gastroenterol (1995) 1.51
Dasl(n)e: the challenge of developing a regional database for autism spectrum disorder. Arch Dis Child (2008) 1.51
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther (2010) 1.51
Left main intervention revisited: early and late outcome of PTCA and stenting. Cathet Cardiovasc Diagn (1997) 1.50
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology (1995) 1.50
Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group. Heart (2000) 1.48
Loss of private health insurance among homosexual men with AIDS. Inquiry (1991) 1.46
The natural history of a non-stenotic bicuspid aortic valve. Br Heart J (1978) 1.46
Diagnosis and treatment of malaria in Britain. BMJ (1993) 1.45
The suicide drop--why? R Soc Health J (1975) 1.45
Nucleoside analogue therapy in fibrosing cholestatic hepatitis--a case report in an HBsAg positive renal transplant recipient. Liver (1998) 1.45
Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol (2005) 1.44
HCV and PCR negativity. Lancet (1992) 1.43
Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. J Virol Methods (2001) 1.43
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol (1998) 1.41
Multiple follicular development associated with herbal medicine. Hum Reprod (1994) 1.41
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
The end of the p value? Br Heart J (1988) 1.41
Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol (2001) 1.40
Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol (1998) 1.40
Of knowledge and deception. J R Soc Med (2000) 1.40
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis (1996) 1.40
A comparison of a disposable skin stapler and nylon sutures for wound closure. S Afr Med J (1982) 1.40